RVVTF (RVVTF) Stock Price & Analysis
RVVTF (RVVTF) fell 10.00% to USD 0.02 as of July 25, 2026 at 13:16 UTC, according to Nexqual real-time market data.
RVVTF last closed at USD 0.02; the session ranged USD 0.02–0.02 on volume of 841 shares. Market capitalization is $7.84M, with a 52-week range of USD 0–0.06 (PNK). Source: Nexqual, July 25, 2026 at 13:16 UTC.
Key Statistics (as of July 25, 2026 at 13:16 UTC)
| Price | USD 0.02 |
|---|---|
| Change | ▼ 10.00% (down) |
| Previous Close | USD 0.02 |
| Open | USD 0.02 |
| Day Range | USD 0.02 – 0.02 |
| 52-Week Range | USD 0 – 0.06 |
| Volume | 841 shares |
| Market Cap | $7.84M |
| Exchange | PNK |
Technical Analysis (RVVTF)
Nexqual's technical model rates RVVTF "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 13:16 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 40.91 (neutral) |
| vs SMA50 | Below (USD 0.02) |
| MACD | -0 (negative) |
Analyst Ratings (RVVTF)
Wall Street analysts rate RVVTF "None", per Nexqual as of July 25, 2026 at 13:16 UTC.
| Consensus Rating | None |
|---|
Earnings (RVVTF)
Source: Nexqual, July 25, 2026 at 13:16 UTC.
Financials & Fundamentals (RVVTF)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -1108.41% |
| Current Ratio | 0.04 |
| Total Cash | $12,665 |
| Total Debt | $70,770 |
| Free Cash Flow | $240,128 |
Source: Nexqual, July 25, 2026 at 13:16 UTC.
Financial Health Score (RVVTF)
Nexqual rates RVVTF's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 13:16 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $13K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$157K |
| Efficiency | Critical — ROE -1108%, ROA -16.4% |
Ownership (RVVTF)
| Insider Ownership | +1.51% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 435.68M |
| Float | 429.35M |
Source: Nexqual, July 25, 2026 at 13:16 UTC.
Leadership (RVVTF)
RVVTF is led by Michael Frank (age 64), Chairman & CEO, per Nexqual as of July 25, 2026 at 13:16 UTC.
| Chairman & CEO | Michael Frank (age 64) |
|---|---|
| Chief Financial Officer | Carmelo Marrelli ACIS, B.Comm., C.A., C.P.A., CGA (age 54) |
| Chief Scientific Officer Consultant | Kelly T. McKee Jr., M.D., M.P.H. (age 75) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MYCOF | MYDECINE INNOVATIONS GROUP INC | USD 0.8 | ▲ 0% |
| RLFTF | MindMaze Therapeutics Holding S | USD 0.2 | ▲ 4.17% |
| EHVVF | Ehave Inc. | USD 0 | ▼ 35.71% |
| TRUFF | Red Light Holland Corp. | USD 0.02 | ▼ 8.33% |
| HAVLF | HAVN LIFE SCIENCES INC. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:16 UTC. This page is informational and not investment advice.